BioLargo reports Q2 2026 results; revenue up 12%
BioLargo (BLGO) reports second-quarter 2026 results with revenue up 12% sequentially and gross margin expanding to 54%.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.